HIV Infection Diagnosis

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

HIV-positive smokers had a higher mean NMR than previously reported in the general population of smokers, suggesting a greater proportion of fast nicotine metabolizers among PLWH.

Effect: decline; Mean NMR 0.47 (HIV+ sample) vs 0.34-0.39 (general population reference)

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null

Being at risk of affective disorders was not significantly associated with HIV infection in this cohort of school students, where HIV prevalence was low (2.2% in women, 0.4% in men).

Effect: null